Independent testing platform SleepHQ has ranked the Eclipse CPAP interface from Bleep Sleep first overall among evaluated CPAP interfaces, assigning a composite score of 97.67 out of 100. The leak rate recorded during testing was 1.68 liters per minute. The Eclipse also ranked first in the comfort category across all tested interfaces.

Bleep Sleep recommends the Eclipse for patients who are initiating CPAP therapy for the first time and for those who have discontinued prior therapy due to mask-related discomfort. The independent data provides a clinical baseline for evaluating the product relative to conventional alternatives.

Product Overview

The Eclipse is a headgear-free nasal CPAP interface. It uses a proprietary magnetic adhesive system called MagSeal. Single-use adhesive pads called Halos are applied to the skin around the nostrils before each use. The Eclipse nasal interface connects to those pads through magnetic alignment, creating a seal that is maintained by CPAP pressure rather than strap tension. As delivered pressure increases, the seal strength increases. As delivered pressure decreases, the connection releases cleanly.

There is no headgear frame, no straps, and no cushion pressing against the nose bridge. The interface is more than 35 percent smaller than leading nasal pillow and nasal mask designs on the market.

Halos come 32 per box, representing a 16-night supply. Each pad is single-use and disposable. DreamPreps cleansing pads are available for skin preparation before application.

Regulatory and Research Background

The Eclipse holds FDA 510(k) clearance under designation K172335. Research and development was supported by a National Institutes of Health SBIR Phase II grant totaling $1,702,820 from the National Heart, Lung, and Blood Institute. The product is manufactured entirely in the United States.

These credentials place the Eclipse in a category of CPAP interfaces with peer-reviewed development backing and federal regulatory clearance, distinguishing it from consumer wellness products that do not carry the same level of independent clinical validation.

Coverage and Billing

The Eclipse is covered by Medicare and most private insurance plans. It bills under HCPCS codes A7034 for nasal mask and A7033 for nasal pillow cushions. The product is also eligible for purchase through HSA and FSA accounts.

Coverage through the Department of Veterans Affairs is also available. Full insurance and VA coverage information is published at bleepsleep.com/pages/insurance-dme-va.

Indicated Patient Population

Bleep Sleep recommends the Eclipse across four primary patient categories based on clinical and user data:

  • Side sleepers: Patients who sleep predominantly on their side report persistent seal failure with conventional headgear-based interfaces. The Eclipse holds seal through positional changes without headgear displacement.
  • Patients with facial hair: Traditional cushion-based interfaces cannot create an effective seal around facial hair. The Halo pads adhere at the nostril margins where beard coverage is typically absent.
  • Patients with claustrophobia or sensory sensitivity: The absence of head straps, a nose bridge frame, and wide cushions reduces the sensory footprint of the interface significantly.
  • Previously non-compliant patients: Patients who abandoned CPAP therapy due to mask discomfort represent a large population with untreated sleep apnea. For these patients, Bleep Sleep recommends the Eclipse as a structurally different option rather than a variation on the same design principles that caused prior non-compliance.

Availability

The Eclipse interface is available directly through Bleep Sleep at bleepsleep.com/collections/bleep-eclipse. Prescribing physicians and sleep clinics can also refer patients through the standard durable medical equipment pathway. Trial programs are available for patients evaluating the interface before committing to ongoing use.

About Bleep Sleep: Bleep Sleep is a US-based medical device company founded by Stuart Heatherington. The company focuses on CPAP adherence improvement through interface design innovation. Its flagship product, the Eclipse, holds FDA 510(k) clearance and was developed with NIH funding from the National Heart, Lung, and Blood Institute.